Perrigo Voluntarily Recalls Select Batches of Cough MedicineBy
Perrigo Company plc reports following the recent recall of certain dosing cups by its supplier, it has initiated a voluntary product recall in the US to the retail level of two batches of its children’s guaifenesin grape liquid (100 mg/5 mL) and three batches of its children’s guaifenesin DM cherry liquid (100 mg guaifenesin and 5 mg dextromethorphan HBr/5 mL) sold in 4 oz. bottles with dosage cup in a box under specified store brand products This recall is being initiated because some packages contain an oral dosing cup with incorrect dose markings.
Commenting on this market action, Perrigo’s Chairman and CEO Joseph C. Papa stated, “There have been no reports of adverse events to Perrigo as a result of the incorrect dosage markings. Perrigo is taking this action to maintain the highest possible product quality standards for our retail customers and consumers. We are taking this action because it is the right thing to do.”
These OTC products are indicated for helping loosen phlegm (mucus) and thin bronchial secretions and making coughs more productive, as well as in the case of the DM product to temporarily relieve coughs due to minor throat irritations, the intensity of coughing, and the impulse to cough. These recalled products are sold by distributors nationwide and distributed through retail stores.